Cargando…
Safety of COVID-19 vaccines: A comparison between adverse drug reactions among vaccines marketed in Europe
Autores principales: | Pardo-Cabello, Alfredo Jose, Manzano-Gamero, Victoria, Luna, Juan de Dios |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Federation of Internal Medicine. Published by Elsevier B.V.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9922576/ https://www.ncbi.nlm.nih.gov/pubmed/36792428 http://dx.doi.org/10.1016/j.ejim.2023.02.014 |
Ejemplares similares
-
Differences in reporting of adverse drug reactions due to COVID-19 vaccines depending on the reporter
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2023) -
Adverse drug reactions in SARS-COV-2 hospitalised patients: a case series with a focus on drug–drug interactions—comment
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2021) -
Placebo: a brief updated review
por: Pardo-Cabello, Alfredo Jose, et al.
Publicado: (2022) -
Comparison of adverse drug reactions among four COVID‐19 vaccines in Europe using the EudraVigilance database: Thrombosis at unusual sites
por: Abbattista, Maria, et al.
Publicado: (2021) -
Comparison of the post-marketing safety profile between influenza and COVID-19 vaccines: An analysis of the vaccine adverse event reporting system
por: Al-Ahmari, Abdullah K., et al.
Publicado: (2022)